|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.997
|
|
|
|
basophil differentiation
|
GO:0030221 |
2 |
0.909
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.777
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.757
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.753
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.744
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.731
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
2 |
0.726
|
Human |
|
|
erythrocyte development
|
GO:0048821 |
3 |
0.716
|
|
|
|
platelet formation
|
GO:0030220 |
4 |
0.700
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
1 |
0.687
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.675
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.650
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.581
|
Human Mouse |
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.569
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.537
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.517
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.511
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
2 |
0.505
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.492
|
|
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.458
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.444
|
|
|
|
chemokine production
|
GO:0032602 |
32 |
0.440
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.439
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.436
|
Mouse |
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.429
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.421
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.387
|
Human |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.371
|
Human |
|
|
spinal cord development
|
GO:0021510 |
4 |
0.366
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.352
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.349
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.339
|
Human |
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.332
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.309
|
Human |
|
|
blood vessel development
|
GO:0001568 |
172 |
0.304
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.292
|
Human |
|
|
right ventricular cardiac muscle tissue morphogenesis
|
GO:0003221 |
2 |
0.280
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.278
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.277
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.270
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.266
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.265
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.261
|
Human |
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.237
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.233
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.231
|
Human Mouse |
|
|
regulation of chemokine production
|
GO:0032642 |
31 |
0.230
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.225
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.221
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.220
|
Human |
|
|
regulation of biomineral tissue development
|
GO:0070167 |
31 |
0.216
|
Mouse |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.216
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.215
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.212
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.206
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.205
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.204
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014067 |
4 |
0.201
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.199
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.198
|
Zebrafish Mouse |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.195
|
Human |
|
|
chromatin modification
|
GO:0016568 |
298 |
0.195
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.193
|
|
|
|
cardiac atrium development
|
GO:0003230 |
10 |
0.190
|
Human |
|
|
myeloid cell development
|
GO:0061515 |
5 |
0.190
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.188
|
Human |
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.183
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.182
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.179
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.175
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.172
|
Mouse |
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.163
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.158
|
Human |
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.155
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.154
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.149
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.147
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.147
|
Human |
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.142
|
Human |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.140
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.133
|
Human |
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.133
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.132
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.131
|
Human |
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.127
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.125
|
Human |
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.124
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.124
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.124
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.122
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.122
|
Human |
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.119
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.117
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.116
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.113
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.111
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.111
|
|
|
|
biomineral tissue development
|
GO:0031214 |
39 |
0.111
|
Mouse |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.109
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.108
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.107
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.107
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.106
|
|
|
|
negative regulation of histone phosphorylation
|
GO:0033128 |
2 |
0.105
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.105
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.105
|
Human |
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.101
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.101
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.100
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.100
|
Human Worm |
|
|
neuroendocrine cell differentiation
|
GO:0061101 |
2 |
0.099
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.098
|
Human |
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
20 |
0.098
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.097
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.097
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.097
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.096
|
Human |
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.095
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.095
|
Human |
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.093
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.092
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.091
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.091
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.091
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.090
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.088
|
Human |
|
|
response to growth factor
|
GO:0070848 |
205 |
0.088
|
Human |
|
|
atrial septum morphogenesis
|
GO:0060413 |
5 |
0.088
|
Human |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.088
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.087
|
Human |
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.087
|
Human |
|
|
metencephalon development
|
GO:0022037 |
2 |
0.087
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.086
|
Human |
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.086
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.084
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.083
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.083
|
Human |
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.081
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.081
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.081
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.080
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.079
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.079
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.079
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.078
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.078
|
Human |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.077
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.076
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.076
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.075
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.074
|
Human |
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.071
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.070
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
2 |
0.069
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.068
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.067
|
Human |
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.067
|
Human |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.067
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.066
|
Human |
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.066
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.064
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.064
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
19 |
0.064
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.063
|
Human |
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.062
|
Human |
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.061
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.061
|
Human |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.060
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
18 |
0.060
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.059
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.059
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.059
|
Fly |
|
|
heart valve formation
|
GO:0003188 |
2 |
0.058
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.058
|
|
|
|
endocardium development
|
GO:0003157 |
2 |
0.058
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.057
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
9 |
0.057
|
Human |
|
|
thyroid hormone generation
|
GO:0006590 |
2 |
0.057
|
Human |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.056
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.056
|
|
|
|
positive regulation of cortisol biosynthetic process
|
GO:2000066 |
1 |
0.056
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
25 |
0.056
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.056
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.055
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
8 |
0.055
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.055
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.055
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.054
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.054
|
|
|
|
gas transport
|
GO:0015669 |
3 |
0.053
|
|
|
|
one carbon compound transport
|
GO:0019755 |
4 |
0.053
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.052
|
Human |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.052
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
16 |
0.052
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.051
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
14 |
0.051
|
|
|
|
platelet activation
|
GO:0030168 |
44 |
0.051
|
|
|
|
positive regulation of transcription regulatory region dna binding
|
GO:2000679 |
8 |
0.050
|
Human |
|
|
coagulation
|
GO:0050817 |
78 |
0.050
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.050
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.049
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.049
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
14 |
0.049
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.048
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.048
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.048
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
4 |
0.048
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.047
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.047
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.047
|
Mouse |
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.047
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.046
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.046
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.046
|
Human |
|
|
eosinophil fate commitment
|
GO:0035854 |
2 |
0.046
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.045
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.045
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.045
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.045
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.045
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.045
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.045
|
|
|
|
positive regulation of chromatin assembly or disassembly
|
GO:0045799 |
2 |
0.045
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.044
|
Human |
|
|
regulation of definitive erythrocyte differentiation
|
GO:0010724 |
2 |
0.044
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.044
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.044
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.044
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.044
|
Human |
|
|
negative regulation of chromatin modification
|
GO:1903309 |
21 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.043
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.043
|
Human |
|
|
blastocyst development
|
GO:0001824 |
3 |
0.043
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.043
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.043
|
Zebrafish Mouse |
|
|
regulation of stem cell maintenance
|
GO:2000036 |
4 |
0.042
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.042
|
Human |
|
|
cell aggregation
|
GO:0098743 |
1 |
0.042
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.042
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.042
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.042
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.042
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.041
|
Human |
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.041
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.041
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.041
|
Human |
|
|
lipid modification
|
GO:0030258 |
84 |
0.040
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.040
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.040
|
Human Mouse |
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.040
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.040
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.040
|
|
|
|
system process
|
GO:0003008 |
349 |
0.040
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.040
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.039
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.039
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.039
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.039
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.039
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
10 |
0.039
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.039
|
Human Worm |
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.039
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.038
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.038
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.038
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.037
|
Human |
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.037
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.037
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.037
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.037
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.036
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.036
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.036
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.036
|
Human |
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.036
|
Human |
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.035
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.035
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.035
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.035
|
|
|
|
cardiac septum development
|
GO:0003279 |
13 |
0.035
|
Human |
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.035
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.035
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.034
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.034
|
Human |
|
|
regulation of fat cell differentiation
|
GO:0045598 |
23 |
0.034
|
Human |
|
|
dna repair
|
GO:0006281 |
198 |
0.034
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
35 |
0.034
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.034
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.034
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.034
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.033
|
Human |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.033
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.033
|
Human |
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.033
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.033
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.033
|
Human |
|
|
regulation of binding
|
GO:0051098 |
111 |
0.033
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.033
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.032
|
Human |
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.032
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
9 |
0.032
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.032
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.032
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.031
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.031
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
7 |
0.031
|
Human |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.031
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.031
|
|
|
|
transepithelial ammonium transport
|
GO:0070634 |
3 |
0.031
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.031
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.031
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.031
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.031
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.031
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.031
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.031
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.031
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.031
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.031
|
Human |
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.030
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.030
|
|
|
|
memory
|
GO:0007613 |
3 |
0.030
|
|
|
|
multicellular organismal iron ion homeostasis
|
GO:0060586 |
1 |
0.030
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.030
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.030
|
Human Fly |
|
|
tissue migration
|
GO:0090130 |
119 |
0.030
|
Human |
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.030
|
|
|
|
intestinal epithelial cell differentiation
|
GO:0060575 |
3 |
0.030
|
Human |
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.030
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.029
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.029
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.029
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.029
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.029
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.029
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.029
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.029
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
76 |
0.029
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.029
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.029
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.029
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.029
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.029
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.029
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.029
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.029
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.028
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.028
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.028
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.028
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.028
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.028
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.028
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.028
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.027
|
|
|
|
cardiac muscle cell fate commitment
|
GO:0060923 |
4 |
0.027
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
1 |
0.027
|
Human |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.027
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.027
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.027
|
Human |
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.027
|
|
|
|
heart valve development
|
GO:0003170 |
8 |
0.027
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.027
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.027
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.027
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.026
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.026
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.026
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.026
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.026
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.026
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.026
|
Human |
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.026
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.026
|
|
|
|
septum secundum development
|
GO:0003285 |
2 |
0.026
|
Human |
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.026
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
29 |
0.026
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.026
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.026
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.026
|
Human |
|
|
regulation of growth
|
GO:0040008 |
165 |
0.026
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
37 |
0.025
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.025
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.025
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.025
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.025
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.025
|
Human |
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.025
|
Human |
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.025
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.025
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.025
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.025
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.025
|
Worm |
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.025
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.025
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
22 |
0.025
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.024
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.024
|
Human |
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.024
|
Human |
|
|
muscle organ development
|
GO:0007517 |
56 |
0.024
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.024
|
|
|
|
interleukin 6 production
|
GO:0032635 |
37 |
0.024
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
1 |
0.024
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.024
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.024
|
Human |
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.024
|
Human |
|
|
positive regulation of endothelial cell differentiation
|
GO:0045603 |
2 |
0.024
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.024
|
Fly |
|
|
histone h4 acetylation
|
GO:0043967 |
47 |
0.024
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.024
|
Zebrafish Mouse Worm |
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.024
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.024
|
Human |
|
|
growth
|
GO:0040007 |
202 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.024
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
42 |
0.023
|
Human |
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.023
|
Human |
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.023
|
|
|
|
platelet aggregation
|
GO:0070527 |
32 |
0.023
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.023
|
Human |
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.023
|
Human |
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.023
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.023
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.023
|
Human |
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.023
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.023
|
Worm |
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.023
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.023
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.023
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.023
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.023
|
Human |
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.023
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.023
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.023
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.023
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.022
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.022
|
|
|
|
head development
|
GO:0060322 |
108 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.022
|
|
|
|
hemoglobin metabolic process
|
GO:0020027 |
3 |
0.022
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.022
|
Fly |
|
|
mitral valve morphogenesis
|
GO:0003183 |
2 |
0.022
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.022
|
|
|
|
negative regulation of transforming growth factor beta2 production
|
GO:0032912 |
2 |
0.021
|
Human |
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.021
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.021
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.021
|
Human |
|
|
double strand break repair
|
GO:0006302 |
101 |
0.021
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.021
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.021
|
Human |
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.021
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
35 |
0.021
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.021
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.021
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.021
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.020
|
|
|
|
hemoglobin biosynthetic process
|
GO:0042541 |
3 |
0.020
|
|
|
|
positive regulation of aldosterone metabolic process
|
GO:0032346 |
2 |
0.020
|
|